Wound Healing and Angiogenic Properties of Supernatants from Lactobacillus Cultures

Experimental Biology and Medicine

Volumn 228, Issue 11, 2003, Pages 1329-1337

  Halper, J ^a   Leshin, L S ^a   Lewis, S J ^a   Li, W I ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

Acute inflammatory response; Angiogenesis; Lymphocyte blastogenesis; Supernatant from Lactobacillus cultures; TNF production

Indexed keywords

ANGIOGENIC FACTOR; COLLAGEN; MATRIGEL; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL WALL; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BLOOD VESSEL; CELL PROLIFERATION; CELL STRAIN; CELL STRAIN AKR 2B; CELL STRAIN J774 A1; COLLAGEN SYNTHESIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG SCREENING; EAR; EPITHELIZATION; FEMALE; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INFLAMMATORY CELL; LACTOBACILLUS; LYMPHOCYTE; LYMPHOCYTE TRANSFORMATION; MACROPHAGE; MOUSE; NEUTROPHIL; NONHUMAN; RAT; SUPERNATANT; SWINE; TISSUE REPAIR; WOUND; WOUND CLOSURE; WOUND HEALING;

ANIMALIA; BACTERIA (MICROORGANISMS); LACTOBACILLUS; MURINAE; RODENTIA; SUIDAE; SUS SCROFA;

EID: 0346218152     PISSN: 15353702     EISSN: None     Source Type: Journal    
DOI: 10.1177/153537020322801111     Document Type: Article

References (35)

1. Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med 341:738-746, 1999.
2. Martin P. Wound healing-aiming for perfect skin regeneration. Science 276:75-81, 1997.
3. Majno G. Chronic inflammation: links with angiogenesis and wound healing. Am J Pathol 153:1035-1039, 1998.
4. Mast BA, Schultz GS. Interactions of cytokines, growth factors, and proteases in acute and chronic wounds. Wound Repair Reg 4:411-420, 1996.
5. Griffioen AW, Molema G. Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. Pharmacol Rev 52:237-268, 2000.
6. Bikfalvi A, Bicknell R. Recent advances in angiogenesis, antiangiogenesis and vascular targeting. Trends Pharmacol Sci 23:576-582, 2002.
7. Li J, Zhang YP, Kirsner RS. Angiogenesis in wound repair: angiogenic growth factors and the extracellular matrix. Microsc Res Tech 60:107-114, 2003.
8. Edmonds M, Bates M, Doxford M, Gough A, Foster A. New treatments in ulcer healing and wound infection. Diabetes Metab Rev 16(Suppl):851-854, 2000.
9. Kantor J, Margolis DJ. Treatment options for diabetic neuropathic foot ulcers: a cost-effectiveness analysis. Dermatol Surg 27:347-351, 2001.
10. Perry BH, Sampson AR, Schwab BH, Karim MR, Smiell JM. A meta-analytic approach to an integrated summary of efficacy: a case study of becaplermin gel. Control Clin Trials 23:389-408, 2002.
11. Robson MC, Phillips TJ, Falanga V, Odenheimer DJ, Parish LC, Jensen JL, Steed DL. Randomized trial of topically applied repifermin (recombinant human keratinocyte growth factor-2) to accelerate wound healing in venous ulcers. Wound Repair Reg 9:347-352, 2001.
12. Sung C, Parry TJ, Riccobene TA, Mahoney A, Roschke V, Murray J, Gu ML, Glenn JK, Caputo F, Farman C, Odenheimer DJ. Pharmacologic and pharmacokinetic profile of repifermin (KGF-2) in monkeys and comparative pharmacokinetics in humans. AAPS Pharm Sci 4:E8, 2002.
13. Ray B. Lactic acid bacteria: Current advances in metabolism, genetics and applications. In: Bozoglu TF, Ray B, Eds. NATO ASI Series. Vol. H98. Berlin Heidelberg: Springer-Verlag, 1996.
14. Wollowski I, Ji ST, Bakalinsky AT, Neudecker C, Pool-Zobel BL. Bacteria used for the production of yogurt inactivate carcinogens and prevent DNA damage in the colon of rats. J Nutr 129:77-82, 1999.
15. Anderson JW, Gilliland SE. Effect of fermented milk (yogurt) containing Lactobacillus acidophilus L1 on serum cholesterol in hypercholesterolemic humans. J Am Coll Nutr 18:43-50, 1999.
16. Pearce J. Effects of milk and fermented dairy products on the blood cholesterol content and profile of mammals in relation to coronary heart disease. Int Dairy J 6:661-672, 1996.
17. Lin MY, Chen TW. Reduction of cholesterol by Lactobacillus acidophilus in culture broth. J Food Drug Anal 8:97-102, 2000.
18. Seydel U, Hawkins L, Schromm AB, Heine H, Scheel O, Koch MHJ, Brandenburg K. The generalized endotoxic principle. Eur J Immunol 33:1586-1592, 2003.
19. Carter BJ, Halper J. Transforming growth factor type e is a novel mediator of wound repair. Wound Repair Regen 4:100-109, 1996.
20. He Z, Ong C, Halper J, Bateman A. Progranulin is a mediator of the wound response. Nat Med 9:225-229, 2003.
21. Brown CA, Halper J. Mitogenic effects of transforming growth factor type e on epithelial and fibroblastic cell lines: comparison with other growth factors. Exp Cell Res 190:233-242, 1990.
22. Satoh M, Hirayoshi K, Yokota S-I, Hosokawa N, Nagata K. Intracellular interaction of collagen-specific stress protein HSP47 with newly synthesized procollagen. J Cell Biol 133:469-483, 1996.
23. Morris DD, Moore JN, Crowe N. Serum tumor necrosis factor activity in horses with colic attributable to gastrointestinal tract disease. Am J Vet Res 52:1565-1569, 1991.
24. Boyum A. Separation of leukocytes from blood and bone marrow. Scand J Clin Lab Invest 21:77-88, 1968.
25. Yang WC, Schultz RD, Spano JS. Isolation and characterization of porcine natural killer (NK) cells. Ver Immunol Immunopathol 14:345-356, 1987.
26. Perdigon G, Nader de Macias ME, Alvarez S, Oliver G, Pesce de Ruiz Holgado AA. Effect of a mixture of L. casei and L. acidophilus administered orally on the immune system in mice. J Food Prot 49:986-998, 1986.
27. Rangavajhyala H, Shahani KM, Sridevi G, Srikumazan S. Nonlipopolysaccharide component(s) of Lactobacillus acidophilus stimulate(s) the production of interleukin-1α and tumor necrosis factor-α by murine macrophages. Nutr Cancer 28:130-134, 1997.
28. Morita H, He F, Fuse T, Ouwehand AC, Hashimoto H, Hosoda M, Mizumach K, Kurisaki J. Cytokine production to the murine macrophage cell line J774.1 after exposure to lactobacilli. Biosci Biotechnol Biochem 66:1963-1966, 2002.
29. Aattour N, Bouras M, Tome D, Marcos A, Lemonnier D. Oral ingestion of lactic-acid bacteria by rats increases lymphocyte proliferation and interferon-γ production. Br J Nutr 87:367-373, 2002.
30. Borruel N, Carol M, Casellas F, Antolin M, De Lara F, Espin E, Naval J, Guarner F, Malagelada JR. Increased mucosal tumour necrosis factor α production in Crohn's disease can be downregulated ex vivo by probiotic bacteria. Gut 51:659-664, 2002.
31. Kano H, Kaneko T, Kaminogawa S. Oral intake of Lactobacillus delbrueckii subsp bulgaricus OLL1073R-1 prevents collagen-induced arthritis in mice. J Food Prot 65:153-160, 2002.
32. McCracken VJ, Chun T, Baldeón, Ahrné S, Molin G, Mackie RI, Gaskins HR. TNF-α sensitizes HT-29 colonic epithelial cells to epithelial cells to intestinal Lactobacilli. Exp Biol Med 227:665-670, 2002.
33. Pochard P, Gosset P, Grangette C, Andre C, Tonnel AB, Pestel J, Mercenier A. Lactic acid bacteria inhibit TH2 cytokine production by mononuclear cells from allergic patients. J Allergy Clin Immunol 110:617-623, 2002.
34. Frengova GI, Simova ED, Beshkova DM, Simov ZI. Exopolysaccharides produced by lactic acid bacteria of kefir grains. Z Naturforsch 57:805-810, 2002.
35. Carbo ML, Braber AF, Koenraad PM. Apparent antifungal activity of several lactic acid bacteria against Penicillium discolor is due to acetic acid in the medium. J Food Prot 65:1309-1316, 2002.